•
Sep 30, 2019

REGENXBIO Q3 2019 Earnings Report

Total Revenue
$14.7M
Previous year: $5.31M
+177.0%
EPS
-$0.94
Previous year: -$0.56
+67.9%
Gross Profit
$12.2M
Previous year: $4.79M
+154.9%
Cash and Equivalents
$79.6M
Previous year: $142M
-44.1%
Free Cash Flow
-$31.8M
Previous year: -$22.9M
+38.8%
Total Assets
$509M
Previous year: $515M
-1.1%

REGENXBIO

REGENXBIO